Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 31262-37-0
2. Delta9-tetrahydrocannabivarin
3. Thcv
4. Thc-v
5. .delta.9-tetrahydrocannabivarin
6. (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
7. Gwp42004
8. Gwp-42004
9. I5ye3i47d8
10. O-4394
11. Cannabivarol, .delta.9-tetrahydro-
12. (-)-.delta.9-trans-tetrahydrocannabivarin
13. 6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar-trans)-
14. 6h-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar-trans)-
15. Unii-i5ye3i47d8
16. 6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar,10ar)-
17. 6h-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar,10ar)-
18. Delta9-thcv
19. .delta.9-tetrahydrocannabivarol
20. Gtpl6418
21. Schembl6856739
22. Chembl2387541
23. .delta.1-tetrahydrocannabidivarol
24. Dtxsid10893920
25. 6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-
26. Zinc5649505
27. Bdbm50511105
28. Hy-u00342
29. .delta.9-trans-tetrahydrocannabivarin
30. Cannabidivarol, .delta.1-tetrahydro-
31. Cs-7377
32. Db11755
33. 6h-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (-)-
34. Delta9-tetrahydrocannabivarin (thcv) 10 Microg/ml In Methanol
35. Delta9-tetrahydrocannabivarin (thcv) 100 Ug/ml In Methanol
36. Delta9-tetrahydrocannabivarin (thcv) 1000 Ug/ml In Methanol
37. Delta9-tetrahydrocannabivarin (thcv) 250 Microg/ml In Acetonitrile
38. (6ar,10ar)-6,6,9-trimethyl-3-propyl-6h,6ah,7h,8h,10ah-benzo[c]isochromen-1-ol
39. 6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6h-benzo[c]chromen-1-ol-, (6ar-trans)-
| Molecular Weight | 286.4 g/mol |
|---|---|
| Molecular Formula | C19H26O2 |
| XLogP3 | 5.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 286.193280068 g/mol |
| Monoisotopic Mass | 286.193280068 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 412 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
THCV does not currently have any FDA, Health Canada, or EMA approved indications.
Compared to THC which demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, THCV acts as a CB1 antagonist and a partial agonist of CB2. Further evidence has also shown that THCV acts as an agonist of GPR55 and l--lysophosphatidylinositol (LPI). Beyond the endocannabinoid system, THCV has also been reported to activate 5HT1A receptors to produce an antipsychotic effect that has therapeutic potential for ameliorating some of the negative, cognitive and positive symptoms of schizophrenia. Furthermore, THCV interacts with different transient receptor potential (TRP) channels including TRPV1, which may contribute to the analgesic, anti-inflammatory and anti-cancer effects of cannabinoids and Cannabis extracts.
ABOUT THIS PAGE
A Tetrahydrocannabivarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrahydrocannabivarin, including repackagers and relabelers. The FDA regulates Tetrahydrocannabivarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrahydrocannabivarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tetrahydrocannabivarin supplier is an individual or a company that provides Tetrahydrocannabivarin active pharmaceutical ingredient (API) or Tetrahydrocannabivarin finished formulations upon request. The Tetrahydrocannabivarin suppliers may include Tetrahydrocannabivarin API manufacturers, exporters, distributors and traders.
Tetrahydrocannabivarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tetrahydrocannabivarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tetrahydrocannabivarin GMP manufacturer or Tetrahydrocannabivarin GMP API supplier for your needs.
A Tetrahydrocannabivarin CoA (Certificate of Analysis) is a formal document that attests to Tetrahydrocannabivarin's compliance with Tetrahydrocannabivarin specifications and serves as a tool for batch-level quality control.
Tetrahydrocannabivarin CoA mostly includes findings from lab analyses of a specific batch. For each Tetrahydrocannabivarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tetrahydrocannabivarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tetrahydrocannabivarin EP), Tetrahydrocannabivarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tetrahydrocannabivarin USP).
LOOKING FOR A SUPPLIER?
